Skip to main content

Table 1 Baseline characteristics of patients with cardiovascular disease

From: Permissive fluid volume in adult patients undergoing extracorporeal membrane oxygenation treatment

Variables

CFB quartiles

Total

P for trend

Quartile 1

Quartile 2

Quartile 3

Quartile 4

Number of patients

101

102

102

101

406

 

Age (yr)

55.0 ± 17.0

56.5 ± 18.0

58.9 ± 19.3

63.1 ± 15.5

58.4 ± 17.7

0.001

Sex (male, %)

74 (73.3)

73 (71.6)

71 (69.6)

59 (58.4)

277 (68.2)

0.025

DM (n, %)

38 (37.6)

36 (35.3)

30 (29.4)

30 (29.7)

134 (33.0)

0.156

Hypertension (n, %)

48 (47.5)

41 (40.2)

35 (34.3)

45 (44.6)

169 (41.6)

0.499

Malignancy (n, %)

6 (5.9)

13 (12.7)

9 (8.8)

7 (6.9)

35 (8.6)

0.937

Charlson comorbidity index

2.1 ± 2.1

2.2 ± 2.0

1.8 ± 1.7

1.1 ± 1.5

1.8 ± 1.9

< 0.001

Weight (kg)

67.6 ± 11.2

66.0 ± 12.9

63.9 ± 12.1

61.4 ± 10.9

64.7 ± 12.0

< 0.001

Body mass index (kg/m2)

24.2 ± 3.3

23.7 ± 3.8

23.4 ± 3.6

23.4 ± 3.3

23.7 ± 3.5

0.085

Body surface area (m2)

1.7 ± 0.2

1.7 ± 0.2

1.7 ± 0.2

1.6 ± 0.1

1.7 ± 0.2

< 0.001

CFB (ml/kg)*

− 4.8 (− 25.2–9.6)

38.2 (27.6–51.4)

109.7 (77.4–137.3)

222.9 (194.6–272.7)

64.7 (20.1–161.7)

< 0.001

Daily fluid balance (ml/kg/d)*,†

2.3 (− 5.0 to 8.9)

13.1 (6.6–27.7)

37.8 (23.8–67.0)

108.4 (63.4–180.6)

26.2 (6.7–68.6)

< 0.001

Cumulative input (ml/kg)*,¶

165.2 (124.7–216.7)

191.6 (168.3–241.8)

248.6 (213.4–280.2)

371.3 (293.3–482.3)

214.5 (157.6–267.2)

< 0.001

Cumulative total output (ml/kg)*,¶

182.0 (138.2–229.7)

149.7 (112.7–201.4)

138.6 (113.6–182.0)

136.8 (91.1–226.3)

153.1 (115.6–201.4)

< 0.001

Cumulative urine output (ml/kg)*,¶

136.0 (68.5–182.5)

100.5 (37.1–143.9)

59.8 (21.7–119.8)

27.1 (10.0–66.6)

95.8 (31.1–150.6)

< 0.001

ICU LOS before ECMO (days)*

1 (0–1)

1 (0–1)

0 (0–1)

0 (0–1)

1 (0–1)

< 0.001

Daily fluid balance before ECMO (ml/kg/d)*,‡

1.4 (− 22.4–19.9)

11.6 (− 15.7–24.4)

11.9 (− 0.6–37.9)

− 0.7 (− 6.2–7.4)

3.1 (− 8.3–21.6)

0.834

ECMO cause (n, %)

 Heart transplant

5 (5.0)

9 (8.8)

2 (2.0)

0 (0.0)

16 (3.9)

0.357

 Other cardiotomy

22 (21.8)

23 (22.5)

20 (19.6)

21 (20.8)

86 (21.2)

 Nonoperative CVD

74 (73.3)

70 (68.6)

80 (78.4)

80 (79.2)

304 (74.9)

ECMO VA mode (n, %)

100 (99.0)

98 (96.1)

99 (97.1)

101 (100.0)

398 (98.0)

0.530

ECMO settings

 Blood flow rate (L/min)

2.8 ± 0.8

3.0 ± 0.8

3.0 ± 1.0

3.1 ± 1.0

2.9 ± 0.9

0.006

 Blood flow rate (L/min/m2)

1.6 ± 0.5

1.8 ± 0.4

1.8 ± 0.6

1.9 ± 0.6

1.8 ± 0.5

< 0.001

 FsO2 (%)

89.4 ± 13.8

87.9 ± 15.1

85.3 ± 15.8

81.3 ± 17.1

85.9 ± 15.7

< 0.001

 ECMO DO2I (ml/min/m2)

272.4 ± 86.7

304.4 ± 101.6

311.9 ± 134.6

344.8 ± 134.9

309.3 ± 119.2

< 0.001

ECMO duration (days)*

4 (2–6)

3 (2–7)

4 (2–7)

3 (2–6)

3 (2–6)

0.231

Mechanical ventilation (n, %)

90 (89.2)

100 (98.5)

97 (95.3)

100 (98.9)

387 (95.3)

0.015

Days of ventilator before ECMO (days)*

1 (0–1)

1 (0–1)

1 (0–1)

0 (0–1)

1 (0–1)

0.155

WBC (× 103/μl)

12.8 ± 6.0

13.8 ± 6.9

14.6 ± 8.5

13.6 ± 6.8

13.7 ± 7.1

0.293

Hemoglobin (g/dl)

11.1 ± 2.4

11.4 ± 2.4

11.0 ± 2.3

10.3 ± 2.4

11.0 ± 2.4

0.008

SaO2 (%)*

98.2 (93.3–99.3)

97.7 (95.4–98.9)

99.3 (97.3–99.8)

99.6 (96.8–99.9)

98.8 (96.2–99.8)

0.001

BUN (mg/dl)

27.3 ± 16.0

27.1 ± 15.2

26.5 ± 11.0

23.6 ± 12.9

26.1 ± 14.0

0.054

Creatinine (mg/dl)

1.5 ± 0.9

1.5 ± 0.8

1.5 ± 0.5

1.4 ± 0.5

1.5 ± 0.7

0.105

eGFR (ml/min/1.73 m2)

60.7 ± 29.5

58.2 ± 26.8

54.6 ± 22.9

58.2 ± 25.8

57.9 ± 26.4

0.348

Albumin (g/dl)

3.0 ± 0.5

2.9 ± 0.6

2.7 ± 0.7

2.6 ± 0.8

2.8 ± 0.7

< 0.001

Bilirubin (mg/dl)

1.8 ± 1.7

2.4 ± 2.6

1.8 ± 1.9

1.2 ± 1.2

1.8 ± 1.9

0.007

CRP (mg/dl)*

32.7 (12.8–82.6)

25.6 (6.4–62.6)

17.9 (4.1–61.9)

9.7 (3.0–47.0)

22.7 (3.6–62.3)

0.001

APACHE II score

23.1 ± 9.7

23.9 ± 8.3

23.7 ± 10.4

24.7 ± 9.7

23.8 ± 9.6

0.274

  1. Abbreviations: APACHE II Acute Physiology and Chronic Health Evaluation II, ARDS Acute respiratory distress syndrome, BUN Blood urea nitrogen, CFB Cumulative fluid balance for 3 days from extracorporeal membrane oxygenation initiation, CRP C-reactive protein, CVD Cardiovascular disease, DM Diabetes mellitus, ECMO Extracorporeal membrane oxygenation, eGFR Estimated glomerular filtration rate, FsO2 Fraction of sweep gas inlet oxygen supplied to extracorporeal membrane oxygenation, SaO2 Oxygen saturation, VA Venoarterial access, WBC White blood cell
  2. *Data are expressed as median and IQR and compared by Jonckheere-Terpstra test
  3. †Fluid balance during entire ECMO treatment
  4. ¶During 3 days from ECMO commencement
  5. ‡Daily fluid balance during ICU admission before ECMO commencement